KORU Medical Systems (KRMD) Stock Price, News & Analysis

Company Overview

KORU Medical Systems, Inc. develops, manufactures and markets portable infusion systems and related accessories for the home and alternate-site infusion markets. The company’s products are designed to support the controlled delivery of specialty drugs, including subcutaneous immunoglobulin (SCIG) therapies, through ambulatory infusion systems.

KORU’s principal product platform is the Freedom Syringe Infusion System, which includes ambulatory syringe pumps such as the Freedom60, FreedomEdge and FreedomIQ, along with flow-control tubing sets and other disposable components. These products are intended to provide patients and caregivers with portable, low-maintenance infusion options that can be used outside traditional clinical settings.

Based in Milford, Connecticut, KORU serves patients, healthcare providers, specialty pharmacies and home-infusion organizations in the United States and international markets. The company’s products are used primarily in the treatment of chronic conditions requiring ongoing infusion therapy, with an emphasis on improving convenience and supporting at-home care.

Key Stats

• Today's Range: $3.30 to $3.87
• 50-Day Range: $2.93 to $3.31
• 52-Week Range: $2.86 to $6.61
• Volume: 206,318 shs
• Average Volume: 184,579 shs
• Market Capitalization: $176.60 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: $6.50
• Consensus Rating: Hold

KORU Medical Systems Stock Analysis - MarketRank™

KORU Medical Systems scored higher than 75% of companies evaluated by MarketBeat, and ranked 180th out of 897 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 3.8 / 5
• Analyst Rating: Hold

Consensus Rating

KORU Medical Systems has received a consensus rating of Hold. The company's average rating score is 2.43, and is based on no strong buy ratings, 4 buy ratings, 2 hold ratings, and 1 sell rating.

Upside Potential

KORU Medical Systems has a consensus price target of $6.50, representing about 85.7% upside from its current price of $3.50.

Amount of Analyst Coverage

KORU Medical Systems has only been the subject of 3 research reports in the past 90 days.

Earnings and Valuation

• Score: 0.6 / 5
• Proj. Earnings Growth: Growing

Earnings Growth

Earnings for KORU Medical Systems are expected to grow in the coming year, from ($0.02) to $0.05 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of KORU Medical Systems is -89.05, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of KORU Medical Systems is -89.05, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Book Value per Share Ratio

KORU Medical Systems has a P/B Ratio of 9.46. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

Short Interest

• Score: 3.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

2.30% of the float of KORU Medical Systems has been sold short.

Short Interest Ratio / Days to Cover

KORU Medical Systems has a short interest ratio ("days to cover") of 6.55.

Change versus previous month

Short interest in KORU Medical Systems has recently decreased by 3.04%, indicating that investor sentiment is improving.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

KORU Medical Systems does not currently pay a dividend.

Dividend Growth

KORU Medical Systems does not have a long track record of dividend growth.

News and Social Media

• Score: 2.2 / 5
• News Sentiment: 0.55

News Sentiment

KORU Medical Systems has a news sentiment score of 0.55. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Healthcare companies.

News Coverage This Week

MarketBeat has tracked 16 news articles for KORU Medical Systems this week, compared to 2 articles on an average week.

MarketBeat Follows

Only 1 people have added KORU Medical Systems to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days.

Company Ownership

• Score: 4.2 / 5
• Insider Trading: Acquiring Shares

Net Insider Buying

Over the last three months, insiders have purchased a net $101,120.00 in company stock, which represents 0.0629% of the company's market cap.

Insider Buying vs. Insider Selling

In the past three months, KORU Medical Systems insiders have bought more of their company's stock than they have sold. Specifically, they have bought $101,120.00 in company stock and sold $0.00 in company stock.

Percentage Held by Insiders

18.50% of the stock of KORU Medical Systems is held by insiders. A high percentage of insider ownership can be a sign of company health.

Percentage Held by Institutions

58.60% of the stock of KORU Medical Systems is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

Company Calendar

• Last Earnings: 11/10/2026
• Today: 11/11/2026
• Canaccord Genuity's MedTech, Diagnostics and Digital Health & Services Forum: 11/11/2026
• 38th Annual Healthcare Conference: 12/01/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Healthcare
• Industry: Healthcare Equipment & Supplies
• Sub-Industry: Healthcare Equipment
• Current Symbol: NASDAQ:KRMD
• CIK: 704440
• Web: www.korumedical.com
• Phone: (845) 469-2042
• Fax: 845-469-5518
• Employees: 73
• Year Founded: 1980

Price Target and Rating

• Average Price Target for KORU Medical Systems: $6.50
• High Price Target: $8.00
• Low Price Target: $4.50
• Potential Upside/Downside: +69.1%
• Consensus Rating: Hold
• Rating Score (0-4): 2.43
• Research Coverage: 7 Analysts

Profitability

• EPS (Trailing Twelve Months): ($0.04)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: 76.90
• P/E Growth: N/A
• Net Income: -$2.64 million
• Net Margins: -4.03%
• Pretax Margin: -4.01%
• Return on Equity: -10.63%
• Return on Assets: -6.51%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 2.72
• Quick Ratio: 2.09

Sales & Book Value

• Annual Sales: $41.13 million
• Price / Sales: 4.29
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $0.37 per share
• Price / Book: 10.39

Miscellaneous

• Outstanding Shares: 45,930,000
• Free Float: 37,435,000
• Market Cap: $176.60 million
• Optionable: Optionable
• Beta: 0.47